Skip to main content
Novakand Pharma AB (publ) (STO:NOVKAN)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.103
-0.021 (-17.04%)
Mar 9, 2026, 4:56 PM CET

Novakand Pharma AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-47.23-44.57-64.89-52.48-45.69
Upgrade
Depreciation & Amortization
---0.360.32
Upgrade
Asset Writedown & Restructuring Costs
18-3--
Upgrade
Other Operating Activities
--0.010.69-0.39
Upgrade
Change in Accounts Receivable
--0.62.39-0.12-0.05
Upgrade
Change in Other Net Operating Assets
-1.06-13.373.813.991.67
Upgrade
Operating Cash Flow
-30.29-58.53-55.67-47.56-44.13
Upgrade
Long-Term Debt Issued
---0.03-
Upgrade
Total Debt Issued
---0.03-
Upgrade
Long-Term Debt Repaid
----0.6-0.3
Upgrade
Total Debt Repaid
----0.6-0.3
Upgrade
Net Debt Issued (Repaid)
----0.57-0.3
Upgrade
Issuance of Common Stock
-73.016.2236.76108.18
Upgrade
Other Financing Activities
--13.81---12.24
Upgrade
Financing Cash Flow
-59.26.2236.1995.64
Upgrade
Net Cash Flow
-30.290.67-49.46-11.3751.51
Upgrade
Free Cash Flow
-30.29-58.53-55.67-47.56-44.13
Upgrade
Free Cash Flow Per Share
-0.25-0.51-0.70-0.82-0.79
Upgrade
Cash Interest Paid
--0.13--
Upgrade
Cash Income Tax Paid
----0.730.39
Upgrade
Levered Free Cash Flow
-19.55-42.82-34.76-28.18-27.35
Upgrade
Unlevered Free Cash Flow
-19.55-42.82-34.76-28.11-27.34
Upgrade
Change in Working Capital
-1.06-13.976.23.871.63
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.